Patents by Inventor Monica Kong-Beltran

Monica Kong-Beltran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE
    Publication number: 20160355606
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 8, 2016
    Inventors: Yan Wu, Cecilia Pui Chi Chiu, Daniel K. Kirchhofer, Andrew Peterson, Ganesh A. Kolumam, Monica Kong Beltran, Paul Moran, Wei Li, Xanthe Lam, Lin Luis, Ada Hui, Whittemore Tingley, John Douglas Davis, Nageshwar R. Budha
  • Anti-PCSK9 antibodies, formulations, dosing, and methods of use
    Patent number: 9266961
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: February 23, 2016
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Cecilia Pui Chi Chiu, Daniel K. Kirchhofer, Andrew Peterson, Ganesh A. Kolumam, Monica Kong Beltran, Paul Moran, Wei Li, Xanthe M. Lam, Lin Luis, Ada Hui
  • PCSK9-BINDING POLYPEPTIDES AND METHODS OF USE
    Publication number: 20140212431
    Abstract: The invention provides PCSK9-binding polypeptides and methods of using the same.
    Type: Application
    Filed: December 19, 2013
    Publication date: July 31, 2014
    Applicant: GENENTECH, INC.
    Inventors: Daniel K. Kirchhofer, Yingnan Zhang, Andrew Scott Peterson, Wei Li, Monica Kong-Beltran, Lijuan Zhou
  • ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSING, AND METHODS OF USE
    Publication number: 20130344085
    Abstract: The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.
    Type: Application
    Filed: June 14, 2013
    Publication date: December 26, 2013
    Inventors: Yan WU, Cecilia Pui Chi CHIU, Daniel K. KIRCHHOFER, Andrew PETERSON, Ganesh A. KOLUMAM, Monica Kong BELTRAN, Paul MORAN, Wei LI, Xanthe LAM, Lin LUIS, Ada HUI, Whittemore TINGLEY, John Douglas DAVIS, Nageshwar R. BUDHA
  • Methods and compositions for modulating hyperstabilized c-met
    Patent number: 8536118
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by inhibiting a hyperstabilized c-met protein.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: September 17, 2013
    Assignee: Genentech, Inc.
    Inventors: Monica Kong-Beltran, Dineli M. Wickramasinghe
  • ANTI-PCSK9 ANTIBODIES AND METHODS OF USE
    Publication number: 20120195910
    Abstract: The invention provides anti-PCSK9 antibodies and methods of using the same.
    Type: Application
    Filed: December 21, 2011
    Publication date: August 2, 2012
    Applicant: GENENTECH, INC.
    Inventors: YAN WU, CECILIA CHIU, DANIEL KIRCHHOFER, ANDREW PETERSON, GANESH KOLUMAM, MONICA KONG BELTRAN, PAUL MORAN, WEI LI
  • METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
    Publication number: 20120171210
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by regulating c-met dimerization and/or binding of ligand to c-met using a c-met antagonist that disrupts c-met multimerization.
    Type: Application
    Filed: February 10, 2012
    Publication date: July 5, 2012
    Applicant: Genentech, Inc.
    Inventors: Monica Kong-Beltran, Dineli M. Wickramasinghe
  • METHODS AND COMPOSITIONS FOR MODULATING HYPERSTABILIZED C-MET
    Publication number: 20100028337
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by inhibiting a hyperstabilized c-met protein.
    Type: Application
    Filed: September 29, 2009
    Publication date: February 4, 2010
    Applicant: Genentech, Inc.
    Inventors: Monica Kong-Beltran, Dineli M. Wickramasinghe
  • METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
    Publication number: 20100016241
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by regulating c-met dimerization and/or binding of ligand to c-met using a c-met antagonist that disrupts c-met multimerization.
    Type: Application
    Filed: September 3, 2009
    Publication date: January 21, 2010
    Applicant: Genentech, Inc.
    Inventors: MONICA KONG-BELTRAN, Dineli M. Wickramasinghe
  • Methods and compositions for modulating hyperstabilized c-met
    Patent number: 7615529
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by inhibiting a hyperstabilized c-met protein.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: November 10, 2009
    Assignee: Genentech, Inc.
    Inventors: Monica Kong-Beltran, Dineli M. Wickramasinghe
  • Methods and Compositions for Inhibiting C-MET Dimerization and Activation
    Publication number: 20070098707
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by regulating c-met dimerization and/or binding of ligand to c-met using a c-met antagonist that disrupts c-met multimerization.
    Type: Application
    Filed: October 2, 2006
    Publication date: May 3, 2007
    Applicant: Genentech, Inc.
    Inventors: Monica Kong-Beltran, Dineli Wickramasinghe
  • Methods and compositions for modulating hyperstabilized c-met
    Publication number: 20060270594
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by inhibiting a hyperstabilized c-met protein.
    Type: Application
    Filed: March 24, 2006
    Publication date: November 30, 2006
    Inventors: Monica Kong-Beltran, Dineli Wickramasinghe
  • Methods and compositions for inhibiting c-met dimerization and activation
    Publication number: 20050233960
    Abstract: The invention provides methods and compositions for modulating the HGF/c-met signaling pathway, in particular by regulating c-met dimerization and/or binding of ligand to c-met using a c-met antagonist that disrupts c-met multimerization.
    Type: Application
    Filed: December 10, 2004
    Publication date: October 20, 2005
    Inventors: Monica Kong-Beltran, Dineli Wickramasinghe